These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37266987)

  • 41. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
    Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
    Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis.
    Yang CP; Liang CS; Chang CM; Yang CC; Shih PH; Yau YC; Tang KT; Wang SJ
    JAMA Netw Open; 2021 Oct; 4(10):e2128544. PubMed ID: 34633423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Menstrual Migraine and Treatment Options: Review.
    Maasumi K; Tepper SJ; Kriegler JS
    Headache; 2017 Feb; 57(2):194-208. PubMed ID: 27910087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.
    Xu H; Han W; Wang J; Li M
    J Headache Pain; 2016 Dec; 17(1):113. PubMed ID: 27957624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of erenumab for migraine prophylaxis during pregnancy: A case report and narrative review.
    Vig SJ; Garza J; Tao Y
    Headache; 2022 Nov; 62(10):1256-1263. PubMed ID: 35467013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications.
    Kelley NE; Tepper DE
    Headache; 2012 Mar; 52(3):467-82. PubMed ID: 22404708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2022 Taiwan Guidelines for Acute Treatment of Migraine.
    Lau CI; Wang YF;
    Acta Neurol Taiwan; 2022 Jun; 31(2)():89-113. PubMed ID: 36153693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rimegepant: acute treatment for migraine headaches.
    Peters GL; Hennessey EK
    Pain Manag; 2021 May; 11(3):259-266. PubMed ID: 33550872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings.
    Polavieja P; Belger M; Venkata SK; Wilhelm S; Johansson E
    J Headache Pain; 2022 Jul; 23(1):76. PubMed ID: 35790906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
    Sheftell FD; Feleppa M; Tepper SJ; Volcy M; Rapoport AM; Bigal ME
    Headache; 2004; 44(7):661-8. PubMed ID: 15209687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative tolerability of treatments for acute migraine: A network meta-analysis.
    Thorlund K; Toor K; Wu P; Chan K; Druyts E; Ramos E; Bhambri R; Donnet A; Stark R; Goadsby PJ
    Cephalalgia; 2017 Sep; 37(10):965-978. PubMed ID: 27521843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis.
    Johnston K; Popoff E; Deighton A; Dabirvaziri P; Harris L; Thiry A; Croop R; Coric V; L'Italien G; Moren J
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jan; 22(1):155-166. PubMed ID: 34148501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimigraine drugs.
    Diener HC; Kaube H; Limmroth V
    J Neurol; 1999 Jul; 246(7):515-9. PubMed ID: 10463349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute Treatment Therapies for Pediatric Migraine: A Qualitative Systematic Review.
    Patniyot IR; Gelfand AA
    Headache; 2016 Jan; 56(1):49-70. PubMed ID: 26790849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.
    Millson DS; Tepper SJ; Rapoport AM
    Expert Opin Pharmacother; 2000 Mar; 1(3):391-404. PubMed ID: 11249525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.
    Jackson JL; Cogbill E; Santana-Davila R; Eldredge C; Collier W; Gradall A; Sehgal N; Kuester J
    PLoS One; 2015; 10(7):e0130733. PubMed ID: 26172390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New "triptans" and other drugs for migraine.
    Med Lett Drugs Ther; 1998 Oct; 40(1037):97-100. PubMed ID: 9793036
    [No Abstract]   [Full Text] [Related]  

  • 60. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
    Ephross SA; Sinclair SM
    Headache; 2014; 54(7):1158-72. PubMed ID: 24805878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.